Pemetrexed ditromethamine dihydrate is a chemotherapy drug used mainly for the treatment of malignant pleural mesothelioma and non-squamous non-small cell lung cancer (NSCLC). It is often administered in combination with cisplatin for initial treatment in these cancers and can be used as monotherapy for maintenance treatment or after prior chemotherapy in non-squamous NSCLC cases. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pemetrexed ditromethamine dihydrate. Its PubChem CID is 135565678.
Pemetrexed tromethamine
| CAS No | 1851348-04-3 |
|---|---|
| Molecular Formula | C28H47N7O14 |
| Molecular Weight | 705.7 g/mol |
| Synonyms | 2-amino-2-(hydroxymethyl)propane-1,3-diol;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid;dihydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pemetrexed ditromethamine dihydrate is a chemotherapy drug used mainly for the treatment of malignant pleural mesothelioma and non-squamous non-small cell lung cancer (NSCLC).
The listed CAS number is 1851348-04-3.
The listed molecular formula is C28H47N7O14.
The listed molecular weight is 705.7 g/mol.
2-amino-2-(hydroxymethyl)propane-1,3-diol;(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid;dihydrate.
The source lists Pemetrexed ditromethamine dihydrate.